Chemokine C-C-Motif Ligand 14 (CCL14) Antibody from ABBEXA LTD

Search, find, compare suppliers for anti-Chemokine C-C-Motif Ligand 14 (CCL14) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityChemokine C-C-Motif Ligand 14 (CCL14)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman
Isotypen/a
Formatbiotin conjugate
Size20 µg, 50 µg, 100 µg, 200 µg+
Concentrationn/a
ApplicationsELISA
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionC-C motif chemokine 14 antibody (Biotin) is a Rabbit polyclonal antibody against C-C motif chemokine 14 conjugated to Biotin.
ImmunogenRecombinant human C-C motif chemokine 14 protein (20-93AA).
Other NamesChemokine Cc-1/Cc-3, Hcc-1/Hcc-3, Hcc-1(1-74), Ncc-2, Small-Inducible Cytokine A14, Ccl14, Ncc2, Scya14, Chemokine Cc-1/Cc-3, Chemokine Cc-1/Cc-3, Chemokine Cc-1/Cc-3 , Chemokine Cc-1/Cc-3 , Hcc-1/Hcc-3, Hcc-1/Hcc-3, Hcc-1/Hcc-3 , Hcc-1/Hcc-3 , Hcc-1(1-74), Hcc-1(1-74), Hcc-1(1-74) , Hcc-1(1-74) , Ncc-2, Ncc-2, Ncc-2 , Ncc-2 , Small-Inducible Cytokine A14, Small-Inducible Cytokine A14, Small-Inducible Cytokine A14 , Small-Inducible Cytokine A14 , Ccl14, Ccl14, Ccl14 , Ccl14 , Ncc2, Ncc2, Ncc2 , Ncc2 , Scya14, Scya14, Scya14 , Scya14
Gene, Accession #CCL14, Gene ID: 6358, NCBI: NP_116738.1, NM_032962.4, UniProt: Q16627
Catalog #abx105232
Priceplease inquire
Order / More InfoChemokine C-C-Motif Ligand 14 (CCL14) Antibody from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.